Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,356 recalls, newest first

Class II · Moderate risk

Extra Strength Headache

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Terminated cGMP deviation Medique Products D-0391-2022
Class II · Moderate risk

Medique Pain-Off

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Terminated cGMP deviation Medique Products D-0390-2022
Class II · Moderate risk

Physicians CARE Extra Strength PAIN RELIEVER

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Terminated cGMP deviation Medique Products D-0389-2022
Class II · Moderate risk

B-Complex

Lack of Processing Controls

Terminated cGMP deviation Valgene Incorporated dba Cape Drugs D-0284-2022
Class II · Moderate risk

artnaturals Hand Sanitizer

CGMP Deviations: Other lots recalled because they were manufactured using common ingredients as the contaminated lot

Terminated cGMP deviation Virgin Scent INC D-0784-2022
Class II · Moderate risk

artnaturals hand sanitizer

CGMP Deviations: Other lots recalled because they were manufactured using common ingredients as the contaminated lot

Terminated cGMP deviation Virgin Scent INC D-0783-2022
Class II · Moderate risk

Maximum Strength Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 41250-989-10 D-0629-2022
Class II · Moderate risk

Maximum Strength Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 41250-989-10 D-0628-2022
Class II · Moderate risk

Sinus Severe

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 55910-696-10 D-0627-2022
Class II · Moderate risk

No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 49035-388-10 D-0626-2022
Class II · Moderate risk

No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 36800-388-10 D-0625-2022
Class II · Moderate risk

Maximum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 30142-388-10 D-0624-2022
Class II · Moderate risk

No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 41163-703-10 D-0623-2022
Class II · Moderate risk

No Drip Nasal Decongestant

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 21130-801-10 D-0622-2022
Class II · Moderate risk

Maximum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 11822-6319-1 D-0621-2022
Class II · Moderate risk

Maximum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 30142-388-10 D-0620-2022

Recalls by year